InvestorsHub Logo
Followers 22
Posts 3749
Boards Moderated 0
Alias Born 05/15/2014

Re: None

Tuesday, 05/26/2020 8:05:31 AM

Tuesday, May 26, 2020 8:05:31 AM

Post# of 183255
OTLK - Outlook Therapeutics Announces $16.0 Million Private Placement to Advance the Development of ONS-5010 / LYTENAVA (bevacizumab-vikg) @1$ below closing price fri
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.